Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes

IUBMB Life

Volumn 67, Issue 8, 2015, Pages 645-658

  Lu, Chunfeng ^a   Zhang, Feng ^a   Xu, Wenxuan ^a   Wu, Xiafei ^a   Lian, Naqi ^a   Jin, Huanhuan ^a   Chen, Qin ^a   Chen, Lianyun ^a   Shao, Jiangjuan ^a   Wu, Li ^a   Lu, Yin ^a   Zheng, Shizhong ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

alcoholic liver disease; curcumin; FXR; lipid accumulation; Nrf2

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CURCUMIN; FARNESOID X RECEPTOR; FATTY ACID SYNTHASE; LACTATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR NRF2; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; NFE2L2 PROTEIN, HUMAN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID STORAGE; LIVER CELL; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LOSS OF FUNCTION MUTATION; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; FATTY LIVER; GENETICS; LIPID METABOLISM; LIVER; LIVER DISEASES, ALCOHOLIC; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; CELL LINE; CURCUMIN; ETHANOL; FATTY LIVER; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIVER; LIVER DISEASES, ALCOHOLIC; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84940531653     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1409     Document Type: Article

References (43)

1. Singal, A. K., and, Jampana, S. C., (2014) Current management of alcoholic liver disease. Curr. Drug Abuse Rev. 7, 18-28.
2. Day, C. P., and, James, O. F., (1998) Hepatic steatosis: innocent bystander or guilty party? Hepatology 27, 1463-1466.
3. Anstee, Q. M., Daly, A. K., and, Day, C. P., (2011) Genetics of alcoholic and nonalcoholic fatty liver disease. Semin. Liver Dis. 31, 128-146.
4. O'Shea, R. S., Dasarathy, S., and, McCullough, A. J., (2010) Alcoholic liver disease. Hepatology 51, 307-328.
5. Fujii, H., and, Kawada, N., (2014) Fibrogenesis in alcoholic liver disease. World J. Gastroenterol. 20, 8048-8054.
6. Ji, C., Chan, C., and, Kaplowitz, N., (2006) Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J. Hepatol. 45, 717-724.
7. Wagner, M., Zollner, G., and, Trauner, M., (2011) Nuclear receptors in liver disease. Hepatology 53, 1023-1034.
8. Zeng, T., Zhang, C. L., Song, F. Y., Zhao, X. L., and, Xie, K. Q., (2012) Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-alpha, and CYP2E1. Food Chem. Toxicol. 50, 485-491.
9. Ali, A. H., Carey, E. J., and, Lindor, K. D., (2015) Recent advances in the development of farnesoid X receptor agonists. Ann. Transl. Med. 3, 5.
10. Zou, Y., Lee, J., Nambiar, S. M., Hu, M., Rui, W., et al., (2014) Nrf2 is involved in maintaining hepatocyte identity during liver regeneration. PLoS One 9, e107423
11. Ma, Y., Huang, Y., Yan, L., Gao, M., and, Liu, D., (2013) Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance. Pharm. Res. 30, 1447-1457.
12. Amano, Y., Shimada, M., Miura, S., Adachi, R., and, Tozawa, R., (2014) Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates. Eur. J. Pharmacol. 723, 108-115.
13. Cariou, B., (2008) The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. Diabetes Metab. 34, 685-691.
14. Wu, W., Zhu, B., Peng, X., Zhou, M., Jia, D., et al., (2014) Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. Biochem. Biophys. Res. Commun. 443, 68-73.
15. Livero, F. A., Stolf, A. M., Dreifuss, A. A., Bastos-Pereira, A. L., Chicorski, R., et al., (2014) The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice. Chem. Biol. Interact. 217, 19-27.
16. Wu, K. C., Liu, J., and, Klaassen, C. D., (2012) Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation. Toxicol. Appl. Pharmacol. 262, 321-329.
17. Zhou, R., Lin, J., and, Wu, D., (2014) Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis. Biochim. Biophys. Acta. 1840, 209-218.
18. Huang, J., Tabbi-Anneni, I., Gunda, V., and, Wang, L., (2010) Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G1211-G1221.
19. Kumar, H., Kim, I. S., More, S. V., Kim, B. W., and, Choi, D. K., (2014) Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat. Prod. Rep. 31, 109-139.
20. Samuhasaneeto, S., Thong-Ngam, D., Kulaputana, O., Suyasunanont, D., and, Klaikeaw, N., (2009) Curcumin decreased oxidative stress, inhibited NF-kappaB activation, and improved liver pathology in ethanol-induced liver injury in rats. J. Biomed. Biotechnol. 2009, 981963
21. Rong, S., Zhao, Y., Bao, W., Xiao, X., Wang, D., et al., (2012) Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity. Phytomedicine 19, 545-550.
22. Lee, H. I., McGregor, R. A., Choi, M. S., Seo, K. I., Jung, U. J., et al., (2013) Low doses of curcumin protect alcohol-induced liver damage by modulation of the alcohol metabolic pathway, CYP2E1 and AMPK. Life Sci. 93, 693-699.
23. Chen, A., Zhang, L., Xu, J., and, Tang, J., (2002) The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem. J. 368, 695-704.
24. Fu, Y., Zheng, S., Lin, J., Ryerse, J., and, Chen, A., (2008) Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol. Pharmacol. 73, 399-409.
25. Huang, Y., Caputo, C. R., Noordmans, G. A., Yazdani, S., Monteiro, L. H., et al., (2014) Identification of novel genes associated with renal tertiary lymphoid organ formation in aging mice. PLoS One 9, e91850
26. Shishodia, S., (2013) Molecular mechanisms of curcumin action: gene expression. Biofactors 39, 37-55.
27. Shehzad, A., and, Lee, Y. S., (2013) Molecular mechanisms of curcumin action: signal transduction. Biofactors 39, 27-36.
28. Lu, X. L., Luo, J. Y., Tao, M., Gen, Y., Zhao, P., et al., (2004) Risk factors for alcoholic liver disease in China. World J. Gastroenterol. 10, 2423-2426.
29. Delima, R. D., Chua, A. C., Tirnitz-Parker, J. E., Gan, E. K., Croft, K. D., et al., (2012) Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice. Hepatology 56, 585-593.
30. Roychowdhury, S., McMullen, M. R., Pisano, S. G., Liu, X., and, Nagy, L. E., (2013) Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57, 1773-1783.
31. Zhou, J., Febbraio, M., Wada, T., Zhai, Y., Kuruba, R., et al., (2008) Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 134, 556-567.
32. Sozio, M. S., Liangpunsakul, S., and, Crabb, D., (2010) The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin. Liver Dis. 30, 378-390.
33. Gao, B., and, Bataller, R., (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572-1585.
34. Horton, J. D., Goldstein, J. L., and, Brown, M. S., (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131.
35. Mandard, S., Muller, M., and, Kersten, S., (2004) Peroxisome proliferator-activated receptor alpha target genes. Cell Mol. Life Sci. 61, 393-416.
36. Li, L., Liu, H., Peng, J., Wang, Y., Zhang, Y., et al., (2013) Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice. Biochem. Biophys. Res. Commun. 441, 880-885.
37. Ludtmann, M. H., Angelova, P. R., Zhang, Y., Abramov, A. Y., and, Dinkova-Kostova, A. T., (2014) Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem. J. 457, 415-424.
38. Liu, J., Wang, X., Liu, R., Liu, Y., Zhang, T., et al., (2014) Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing modulating in rats. Chem. Biol. Interact. 221, 88-98.
39. Jiao, Y., Lu, Y., and, Li, X. Y., (2015) Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacol. Sin. 36, 44-50.
40. Watanabe, M., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., et al., (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113, 1408-1418.
41. Kay, H. Y., Kim, W. D., Hwang, S. J., Choi, H. S., Gilroy, R. K., et al., (2011) Nrf2 inhibits LXRalpha-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid. Redox Signal. 15, 2135-2146.
42. Zou, W., Chen, C., Zhong, Y., An, J., Zhang, X., et al., (2013) PI3K/Akt pathway mediates Nrf2/ARE activation in human L02 hepatocytes exposed to low-concentration HBCDs. Environ. Sci. Technol. 47, 12434-12440.
43. Wu, J., Williams, D., Walter, G. A., Thompson, W. E., and, Sidell, N., (2014) Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells. Exp. Cell Res. 328, 351-360.